HUAWEI Cloud Pangu Drug Molecule Model

HUAWEI Cloud Pangu is an AI tool designed for accelerating drug discovery by optimizing drug molecules. It offers features such as Molecule Search, Molecule Optimizer, and Pocket Molecule Design. Users can submit molecules for optimization and view historical optimization results. The tool is based on the MindSpore framework and has been visited over 300,000 times since August 23, 2021.

VantAI is an AI application focused on generative AI-enabled drug discovery. Their mission is to unlock a new chapter in medicine by making protein interactions programmable. They have an integrated discovery platform with phase-shifting technologies designed to unlock the full potential of the proximity modulator modality. VantAI collaborates with industry leaders to build the future of therapeutic design. The company has launched Neo-1, the first AI model to rewire molecular interactions by unifying structure prediction and generation.

Lavo Life Sciences is an AI-accelerated crystal structure prediction application that helps in drug development by providing accurate predictions for small molecule drugs. The application utilizes AI technology to optimize solid-state formulations, reduce turnaround time, mitigate risks, and discover novel polymorphs, ultimately streamlining the pharmaceutical research and development process.

Genesis Therapeutics is an AI platform that leverages cutting-edge technology to revolutionize drug discovery and development processes. The platform integrates advanced algorithms and machine learning models to accelerate the identification of novel drug candidates and optimize their properties. By combining computational simulations with experimental data, Genesis Therapeutics offers a comprehensive solution to streamline the drug development pipeline and bring innovative therapies to market faster. The platform is designed to empower researchers and pharmaceutical companies with powerful tools for predicting drug-target interactions, optimizing molecular structures, and prioritizing lead compounds for further investigation.

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Allchemy is a resource-aware AI platform for drug discovery. It combines state-of-the-art computational synthesis with AI algorithms to predict molecular properties. Within minutes, Allchemy creates thousands of synthesizable lead candidates meeting user-defined profiles of drug-likeness, affinity towards specific proteins, toxicity, and a range of other physical-chemical measures. Allchemy encompasses the entire resource-to-drug design process and has been used in academic, corporate and classified environments worldwide to: Design synthesizable leads targeting specific proteins Evolve scaffolds similar to desired drugs Design “circular” drug syntheses from renewable materials Interface with and instruct automated synthesis platforms and optimize pilot-scale processes Operate “iterative synthesis” schemes Predict side reactions and create forensic “synthetic signatures” of hazardous/toxic molecules Design synthetic degradation and recovery cycles for various types of feedstocks and functional target molecules

Kuano is an AI tool that focuses on redefining drug discovery using Quantum and AI technologies. The platform offers world-class scientific expertise in quantum physics, AI, and medicinal chemistry to revolutionize the drug design process. Kuano aims to leverage cutting-edge technologies to accelerate the discovery of new drugs and improve healthcare outcomes.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health. The platform is trusted by partners in precision health and medicine and is continuously evolving to disrupt drug discovery times and costs at all stages.

Valo is a company that uses AI-driven technology to transform the discovery and development of life-changing medicines. They combine machine learning, tissue biology, and patient data to create a suite of powerful capabilities that bring the future of drug discovery and development to bear. Valo's team of software engineers, data scientists, biologists, medicinal chemists, and big-picture thinkers are dedicated to advancing the combined power of technology and patient data.

Chemprop is a PyTorch-based framework for training and evaluating message-passing neural networks (MPNNs) for molecular property prediction. Originally developed for research purposes, Chemprop offers a comprehensive set of tools and features for training models and analyzing molecular representations. The package underwent a recent major release (v2.0.0) with significant improvements and updates.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

HUAWEI Cloud Pangu is an AI tool designed for accelerating drug discovery by optimizing drug molecules. It offers features such as Molecule Search, Molecule Optimizer, and Pocket Molecule Design. Users can submit molecules for optimization and view historical optimization results. The tool is based on the MindSpore framework and has been visited over 300,000 times since August 23, 2021.

Google DeepMind is an AI research company that aims to develop artificial intelligence technologies to benefit the world. They focus on creating next-generation AI systems to solve complex scientific and engineering challenges. Their models like Gemini, Veo, Imagen 3, SynthID, and AlphaFold are at the forefront of AI innovation. DeepMind also emphasizes responsibility, safety, education, and career opportunities in the field of AI.

Pinecone is a vector database designed to build knowledgeable AI applications. It offers a serverless platform with high capacity and low cost, enabling users to perform low-latency vector search for various AI tasks. Pinecone is easy to start and scale, allowing users to create an account, upload vector embeddings, and retrieve relevant data quickly. The platform combines vector search with metadata filters and keyword boosting for better application performance. Pinecone is secure, reliable, and cloud-native, making it suitable for powering mission-critical AI applications.

CodeScope is an AI tool designed to help users build and edit incredible AI applications. It offers features like one-click code and SEO performance optimization, AI app builder, API creation, headless CMS, development tools, and SEO reporting. CodeScope aims to revolutionize the development workflow by providing a comprehensive solution for developers and marketers to enhance collaboration and efficiency in the digital development and marketing landscape.

Helix AI is a private GenAI platform that enables users to build AI applications using open source models. The platform offers tools for RAG (Retrieval-Augmented Generation) and fine-tuning, allowing deployment on-premises or in a Virtual Private Cloud (VPC). Users can access curated models, utilize Helix API tools to connect internal and external APIs, embed Helix Assistants into websites/apps for chatbot functionality, write AI application logic in natural language, and benefit from the innovative RAG system for Q&A generation. Additionally, users can fine-tune models for domain-specific needs and deploy securely on Kubernetes or Docker in any cloud environment. Helix Cloud offers free and premium tiers with GPU priority, catering to individuals, students, educators, and companies of varying sizes.

Analog AI is an AI application designed as assistants for asynchronous communication with video conference calls while working remotely. It addresses the timezone problem by allowing users to share their progress with Analog human who will attend the call on their behalf. The application offers easy training, human-like cognitive capabilities, emotional intelligence, and the ability to express emotions and mood authentically. Analog AI aims to seamlessly integrate into team conversations and provide a unique digital experience.

Mxface is a leading face recognition API technology that offers advanced computer vision and AI APIs for developers. The platform provides services like face detection, face comparing, face landmarks, face attributes, face search, iris recognition, fingerprint recognition, and people detection. Mxface ensures data security, real-time face recognition, precision, easy face enrollment, and device integration. It is a cloud-based facial recognition solution that supports various use cases and offers comprehensive security features.

SiMa.ai is an AI application that offers high-performance, power-efficient, and scalable edge machine learning solutions for various industries such as automotive, industrial, healthcare, drones, and government sectors. The platform provides MLSoC™ boards, DevKit 2.0, Palette Software 1.2, and Edgematic™ for developers to accelerate complete applications and deploy AI-enabled solutions. SiMa.ai's Machine Learning System on Chip (MLSoC) enables full-pipeline implementations of real-world ML solutions, making it a trusted platform for edge AI development.

Happi.ai is a virtual mental health coach application that provides 24/7 support for individuals dealing with anxiety, depression, and loneliness. The AI companion, Olivia, offers personalized assistance, compassionate listening, and non-judgmental support. The platform prioritizes user privacy with top-tier encryption and offers expert insights and proactive suggestions for emotional well-being. Happi analyzes facial expressions, voice patterns, and speech content to identify moments of stress and provide real-time feedback to manage stress and improve emotional health.

HUAWEI Cloud Pangu is an AI tool designed for accelerating drug discovery by optimizing drug molecules. It offers features such as Molecule Search, Molecule Optimizer, and Pocket Molecule Design. Users can submit molecules for optimization and view historical optimization results. The tool is based on the MindSpore framework and has been visited over 300,000 times since August 23, 2021.

AppAsap is an AI-driven application development platform that allows users to create mobile apps effortlessly by simply chatting with the AI. The platform offers a range of features including database visualization, API playground, admin CMS, frontend builder, and more. It is designed to be simple, secure, and scalable, with built-in GDPR compliance and robust encryption. Users can generate APIs in minutes, access clean source code, and benefit from seamless visual customization. AppAsap is built with Express.js, React, Prisma, Typescript, RDS, and ECS, ensuring high-quality performance and reliability. The platform offers flexible pricing options to suit different needs, with a free trial available. Get in touch with the support team via email or Discord for assistance and start creating your app today.

Organz.ai is an innovative AI-powered application that helps users in decluttering and organizing their living or working spaces. By leveraging artificial intelligence, Organz.ai analyzes uploaded photos of cluttered areas and generates visualizations of organized spaces. The app provides personalized recommendations for decluttering strategies and suggests organizational products tailored to the user's specific needs. With features like AI clutter recommendation, personalized product selection, direct purchase links, and AI-generated suggestions, Organz.ai simplifies the process of decluttering and enhances the overall user experience.

Luxonis is a platform that offers robotic vision solutions through high-resolution cameras with depth vision and on-chip machine learning capabilities. Their products include OAK Cameras and Modules, providing features like Stereo Depth Sensing, Computer Vision, Artificial Intelligence, and Cloud Management. Luxonis enables the development of computer vision products and companies by offering performant and affordable hardware solutions. The platform caters to enterprises and hobbyists, empowering them to easily build embedded vision systems.

tuul.ai is an AI application that specializes in providing custom solutions for AI marketing, AgTech, and data generation-curation. The platform offers innovative AI systems and services tailored to meet the specific needs of clients in various industries. From livestock biometric ID to AI veterinary platforms, tuul.ai leverages cutting-edge technology to deliver impactful solutions for businesses and individuals seeking to harness the power of artificial intelligence.

Backmesh is an AI tool that serves as a proxy on edge CDN servers, enabling secure and direct access to LLM APIs without the need for a backend or SDK. It allows users to call LLM APIs from their apps, ensuring protection through JWT verification and rate limits. Backmesh also offers user analytics for LLM API calls, helping identify usage patterns and enhance user satisfaction within AI applications.

Greenbids is an AI application designed to minimize inefficiencies and enhance media performance in digital advertising, contributing to decarbonization efforts. By utilizing Machine Learning, Greenbids saves 1000 tons of CO2 every month and drives sustainable media effectiveness across the advertising ecosystem. The platform offers a unique solution to decrease ads' carbon footprint, with an average carbon intensity reduction of 36% and a 27% increase in media effectiveness. Greenbids aims to address the environmental impact of programmatic advertising by providing a more sustainable and efficient alternative.

NeuReality is an AI-centric solution designed to democratize AI adoption by providing purpose-built tools for deploying and scaling inference workflows. Their innovative AI-centric architecture combines hardware and software components to optimize performance and scalability. The platform offers a one-stop shop for AI inference, addressing barriers to AI adoption and streamlining computational processes. NeuReality's tools enable users to deploy, afford, use, and manage AI more efficiently, making AI easy and accessible for a wide range of applications.

Future AGI is a revolutionary AI data management platform that aims to achieve 99% accuracy in AI applications across software and hardware. It provides a comprehensive evaluation and optimization platform for enterprises to enhance the performance of their AI models. Future AGI offers features such as creating trustworthy, accurate, and responsible AI, 10x faster processing, generating and managing diverse synthetic datasets, testing and analyzing agentic workflow configurations, assessing agent performance, enhancing LLM application performance, monitoring and protecting applications in production, and evaluating AI across different modalities.

Langflow is a new, visual framework for building multi-agent and RAG applications. It is open-source, Python-powered, fully customizable, and LLM and vector store agnostic. Langflow empowers developers to rapidly prototype and build AI applications with its user-friendly interface and powerful features. Whether you're a seasoned AI developer or just starting out, Langflow provides the tools you need to bring your AI ideas to life.

The website is a platform dedicated to discussing and analyzing various developments and advancements in the field of AI, particularly focusing on Large Language Models (LLMs) such as GPT-5. It provides detailed insights, release notes, and discussions on AI models, applications, and security concerns. The website covers a wide range of topics related to AI, including prompt injections, spatial joins, memory features, and project-specific memory usage.

Synthace is a software and expertise platform designed for Discovery Biology Teams to streamline and optimize their experiments in assay development, media optimization, and purification process development. The platform offers software solutions, training, and on-site support from specialists to help scientists conduct experiments more efficiently and effectively. By leveraging multifactorial methods and automation, Synthace aims to accelerate drug discovery processes and deliver faster, definitive results.

VantAI is an AI application focused on generative AI-enabled drug discovery. Their mission is to unlock a new chapter in medicine by making protein interactions programmable. They have an integrated discovery platform with phase-shifting technologies designed to unlock the full potential of the proximity modulator modality. VantAI collaborates with industry leaders to build the future of therapeutic design. The company has launched Neo-1, the first AI model to rewire molecular interactions by unifying structure prediction and generation.

CEBRA is a self-supervised learning algorithm designed for obtaining interpretable embeddings of high-dimensional recordings using auxiliary variables. It excels in compressing time series data to reveal hidden structures, particularly in behavioral and neural data. The algorithm can decode neural activity, reconstruct viewed videos, decode trajectories, and determine position during navigation. CEBRA is a valuable tool for joint behavioral and neural analysis, providing consistent and high-performance latent spaces for hypothesis testing and label-free applications across various datasets and species.

Mind-Video is an AI tool that focuses on high-quality video reconstruction from brain activity data. It bridges the gap between image and video brain decoding by utilizing masked brain modeling, multimodal contrastive learning, spatiotemporal attention, and co-training with an augmented Stable Diffusion model. The tool aims to recover accurate semantic information from fMRI signals, enabling the generation of realistic videos based on brain activities.

Boff.ai is an AI tool that connects professionals with academia to unlock opportunities and funding for research and development teams. It helps users ask specific questions across various topics and sources replies from experts in the field. The platform ensures privacy and focuses on solutions required, making it a trusted resource for 30,000 academics and R&D professionals.

Modality.AI is an AI application that has developed an automated, clinically validated system to assess neurological and psychiatric states both in clinic and remotely. The platform utilizes conversational AI to monitor conditions accurately and consistently, allowing researchers and clinicians to review data in near real-time and monitor treatment response over time. Modality.AI collaborates with world-class AI/Machine Learning experts and leading institutions to provide a HIPAA-compliant system for assessing various indications such as ALS, Parkinson's, depression, autism, Huntington's Disease, schizophrenia, and mild cognitive impairment. The platform enables convenient monitoring at home through streaming and analysis of speech and facial responses, without the need for special software or apps. Modality.AI is accessible on various devices with a browser, webcam, and microphone, offering a new approach to efficient and cost-effective clinical trials.